Boston Scientific Corporation
BSX Healthcare Medical Devices
Boston Scientific Corporation’s revenue for fiscal 2025 (year ended December 2025) was $20.1 billion, up 19.9% from fiscal 2024. In the quarter to June 2026, revenue grew 7.53%, EPS grew 14.8%, free cash flow grew 13.3% and total debt rose 8.95%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
Follow BSX
Boston Scientific Corporation (BSX) Return on assets
Boston Scientific Corporation's return on assets over the twelve months to 30 June 2026 was 8.47%, up 1.5 percentage points from fiscal 2025 (6.98%). Over the past ten years it has ranged from −1.36% (fiscal 2015) to 18.2% (fiscal 2019); the current reading is higher than 82% of that period. That is above the Medical Devices industry median of −19.7% and above the Healthcare sector median of −30.9%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | 6.98% | 2.01 |
| FY2024 | 4.97% | 0.33 |
| FY2023 | 4.64% | 2.66 |
| FY2022 | 1.98% | (1.15) |
| FY2021 | 3.13% | 3.50 |
| FY2020 | −0.37% | (18.60) |
| FY2019 | 18.2% | 9.88 |
| FY2018 | 8.35% | 7.79 |
| FY2017 | 0.56% | (1.36) |
| FY2016 | 1.92% | 3.28 |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| DXCM DexCom, Inc. compare | 14.5% |
| BSX Boston Scientific Corporation | 8.47% |
| SYK Stryker Corporation compare | 7.91% |
| STE STERIS plc compare | 7.62% |
| EW Edwards Lifesciences Corporation compare | 7.35% |
| MDT Medtronic PLC compare | 5.68% |
| ABT Abbott Laboratories compare | 5.62% |
| GEHC GE HealthCare Technologies Inc. compare | 5.45% |
| PHG Koninklijke Philips N.V. compare | 4.21% |
| Medical Devices industry median | −19.7% |
| Healthcare sector median | −30.9% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on BSX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement